Microglia Produce and Hydrolyze Palmitoylethanolamide

Overview

Journal Neuropharmacology

Specialties Neurology
Pharmacology

Date 2007 Jul 17

PMID 17631917

Citations 44

Authors

Giulio G Muccioli

Nephi Stella

Affiliations

Soon will be listed here.

Abstract

Microglial cell activation and migration play an important role in neuroinflammation propagation. While it is known that the lipid transmitter palmitoylethanolamide (PEA) regulates microglial migration by interacting with a cannabinoid-like receptor, the production and inactivation of this lipid by microglia has never been addressed directly. Here we show that the mouse microglial cell line BV-2 produces and hydrolyzes PEA. The carbamate compound URB602 inhibits PEA hydrolysis in BV-2 cell homogenates and increases PEA levels in intact cells, whereas the FAAH inhibitor URB597 and serine-hydrolase inhibitor MAFP do not affect PEA levels in intact cells. This unique pharmacological profile of inhibitors on PEA hydrolysis suggests the involvement of a previously undescribed enzyme that degrades PEA. This enzyme expressed by microglia constitutes a promising target for controlling the propagation of neuroinflammation.

Citing Articles

Palmitoylethanolamide and Luteolin for Postinfectious Olfactory Disorders: How Clinically Meaningful Is Its Effect?.

Gellrich J, Czaplewski L, Hahner A, Hummel T ORL J Otorhinolaryngol Relat Spec. 2024; 86(3-4):118-123.

PMID: 38861957 PMC: 11651318. DOI: 10.1159/000539651.

URB937 Prevents the Development of Mechanical Allodynia in Male Rats with Trigeminal Neuralgia.

Demartini C, Greco R, Zanaboni A, Francavilla M, Facchetti S, Tassorelli C Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004491 PMC: 10675761. DOI: 10.3390/ph16111626.

RT-DOb, a switch gene for the gene pair {Csf1r, Milr1}, can influence the onset of Alzheimer's disease by regulating communication between mast cell and microglia.

Khayer N, Motamed N, Marashi S, Goshadrou F PLoS One. 2023; 18(7):e0288134.

PMID: 37410787 PMC: 10325119. DOI: 10.1371/journal.pone.0288134.

Palmitoylethanolamide and Related ALIAmides for Small Animal Health: State of the Art.

Rocca G, Re G Biomolecules. 2022; 12(9).

PMID: 36139024 PMC: 9496254. DOI: 10.3390/biom12091186.

Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles.

Sionov R, Steinberg D Biomedicines. 2022; 10(3).

PMID: 35327432 PMC: 8945038. DOI: 10.3390/biomedicines10030631.

References

Boger D, Fecik R, Patterson J, Miyauchi H, Patricelli M, Cravatt B . Fatty acid amide hydrolase substrate specificity. Bioorg Med Chem Lett. 2000; 10(23):2613-6. DOI: 10.1016/s0960-894x(00)00528-x. View

Zhang D, Saraf A, Kolasa T, Bhatia P, Zheng G, Patel M . Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets. Neuropharmacology. 2007; 52(4):1095-105. DOI: 10.1016/j.neuropharm.2006.11.009. View

Jonsson K, Vandevoorde S, Lambert D, Tiger G, Fowler C . Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Br J Pharmacol. 2001; 133(8):1263-75. PMC: 1621151. DOI: 10.1038/sj.bjp.0704199. View

Stella N, Piomelli D . Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur J Pharmacol. 2001; 425(3):189-96. DOI: 10.1016/s0014-2999(01)01182-7. View

Walter L, Franklin A, Witting A, Moller T, Stella N . Astrocytes in culture produce anandamide and other acylethanolamides. J Biol Chem. 2002; 277(23):20869-76. DOI: 10.1074/jbc.M110813200. View

Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A . Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med. 2002; 9(1):76-81. DOI: 10.1038/nm803. View

Jaggar S, Hasnie F, Sellaturay S, Rice A . The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain. 1998; 76(1-2):189-99. DOI: 10.1016/s0304-3959(98)00041-4. View

Ueda N, Yamanaka K, Terasawa Y, Yamamoto S . An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors. FEBS Lett. 1999; 454(3):267-70. DOI: 10.1016/s0014-5793(99)00820-0. View

Lambert D, DiPaolo F, Sonveaux P, Kanyonyo M, Govaerts S, Hermans E . Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors. Biochim Biophys Acta. 1999; 1440(2-3):266-74. DOI: 10.1016/s1388-1981(99)00132-8. View

10.

Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A . The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol. 2004; 67(1):15-9. DOI: 10.1124/mol.104.006353. View

11.

Patel S, Carrier E, Vanessa Ho W, Rademacher D, Cunningham S, Reddy D . The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. J Lipid Res. 2004; 46(2):342-9. DOI: 10.1194/jlr.M400377-JLR200. View

12.

Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G . Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther. 2004; 313(1):352-8. DOI: 10.1124/jpet.104.078980. View

13.

Tsuboi K, Sun Y, Okamoto Y, Araki N, Tonai T, Ueda N . Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J Biol Chem. 2005; 280(12):11082-92. DOI: 10.1074/jbc.M413473200. View

14.

Hohmann A, Suplita R, Bolton N, Neely M, Fegley D, Mangieri R . An endocannabinoid mechanism for stress-induced analgesia. Nature. 2005; 435(7045):1108-12. DOI: 10.1038/nature03658. View

15.

Sun Y, Tsuboi K, Zhao L, Okamoto Y, Lambert D, Ueda N . Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. Biochim Biophys Acta. 2005; 1736(3):211-20. DOI: 10.1016/j.bbalip.2005.08.010. View

16.

Leung D, Saghatelian A, Simon G, Cravatt B . Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry. 2006; 45(15):4720-6. PMC: 1538545. DOI: 10.1021/bi060163l. View

17.

Witting A, Chen L, Cudaback E, Straiker A, Walter L, Rickman B . Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proc Natl Acad Sci U S A. 2006; 103(16):6362-7. PMC: 1458883. DOI: 10.1073/pnas.0510418103. View

18.

Mackie K, Stella N . Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J. 2006; 8(2):E298-306. PMC: 3231556. DOI: 10.1007/BF02854900. View

19.

Simon G, Cravatt B . Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J Biol Chem. 2006; 281(36):26465-72. DOI: 10.1074/jbc.M604660200. View

20.

Liu J, Wang L, Harvey-White J, Osei-Hyiaman D, Razdan R, Gong Q . A biosynthetic pathway for anandamide. Proc Natl Acad Sci U S A. 2006; 103(36):13345-50. PMC: 1557387. DOI: 10.1073/pnas.0601832103. View